The safety of NovoSeven® RT (Coagulation Factor VIIa [Recombinant]) is proven
In hemophilia, a collection of blood in an area, such as a muscle or joint. safely is important. There are many safety concerns you should be aware of. Safety should never be ignored when treating any bleeding disorder.
NovoSeven® RT has many safety features:
- Free of human blood or plasma
The fluid part of the blood that contains clotting factors and other proteins.
- Risk of
Relating to or caused by thrombosis. Thrombosis is an event that takes place when veins or arteries become blocked by platelets that are working to "plug" an injury, preventing blood from flowing normally through the body, and possibly causing a stroke.adverse events was less than 1%*
- Associated with a decrease in inhibitor
A substance made by the body that attacks factor so it cannot work as well. For example, a Factor VIII (8) inhibitor would keep Factor VIII from working with other factors and platelets to stop bleeding. titers Titer
Concentration or strength of a substance; measures the strength of an inhibitor in a person’s blood. in hemophilia A Hemophilia A
A bleeding disorder caused by lack of Factor VIII (8). It is sometimes called classic or standard hemophilia. or B Hemophilia B
A bleeding disorder caused by lack of Factor IX (9). when used as the only factor Factor
A protein in the blood that helps form blood clots. agent in a study
*In patients with hemophilia A or B with inhibitors and acquired hemophilia.